News IQ-AI Limited BOERSE MUENCHEN

Equities

Market Closed - BOERSE MUENCHEN Other stock markets 01:14:04 29/06/2024 am IST			5-day change	1st Jan Change
0.0185 ^EUR	-2.63%		-9.76%	-65.74%

25/06	IQ-AI subsidiary opens expanded access programme	AN
14/06	IQ-AI Says Brain Cancer Drug Delays Disease Progression in Early-stage Study	MT

IQ-AI subsidiary opens expanded access programme	25/06	AN
IQ-AI Says Brain Cancer Drug Delays Disease Progression in Early-stage Study	14/06	MT
IQ-AI team begins defining phase 2 protocol for oral gallium maltolate	14/06	AN
IQ-AI Ltd. Provides Update on Phase 1 Update	14/06	CI
Celadon ships to US; Oxford BioDynamics-Goodbody pact	24/05	AN
IQ-AI subsidiary gets second FDA rare paediatric disease designation	20/05	AN
IQ-AI's Imaging Biometrics Gets Second Rare Disease Designation for Drug Candidate	20/05	MT
Ingenta trades in line; Triple Point Social NAV up	17/05	AN
IQ-AI Unit Delivers Software to Insel Gruppe	17/05	MT
IQ-AI subsidiary gets rare paediatric disease designation FDA	10/05	AN
IQ-AI's Imaging Biometrics Obtains Rare Pediatric Disease Designation for Lead Drug Candidate	10/05	MT
EARNINGS AND TRADING: Trident Royalties swings to profit	02/05	AN
IQ-AI Limited Provides Revenue Guidance for the Financial Year 2024	29/04	CI
IQ-AI Limited Reports Earnings Results for the Full Year Ended December 31, 2023	29/04	CI
IQ-AI advances glioblastoma clinical trial, eyes phase two in 2025	26/02	AQ
IQ-AI's Broker Exercises Option to Buy Shares in Placing	26/02	MT
IQ-AI Plans Share Placing to Advance Oral Anti-tumor Agent Development	22/02	MT
IQ-AI shares sink on discounted placing fundraise	22/02	AN
IQ-AI Unit to Revise, Resubmit Pediatric Rare Disease Designation Application After US FDA Feedback	09/02	MT
IQ-AI subsidiary asked by FDA to resubmit and modify application	09/02	AN

No results for this search